Sudden Cardiac Arrest Clinical Trial
Official title:
A Post Market Clinical Follow-up Study to Evaluate the Safety and Clinical Performance of the Tempus Pro, a Multi-parameter Vital Signs Monitoring Device With Specific Reference to ECG Recordings and Data Transmission Using Telemedicine
Verified date | May 2024 |
Source | Philips Clinical & Medical Affairs Global |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
A multicenter, prospective and retrospective, observational, post market study.
Status | Enrolling by invitation |
Enrollment | 100 |
Est. completion date | June 28, 2024 |
Est. primary completion date | June 28, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: Patients monitored by using Tempus Pro during pre-hospital care (ambulance transportation) One or more 12-lead ECG recorded Use of 3 or more of the following sensors to measure vital signs - NIBP (Non-Invasive Blood Pressure) - HR (Heart Rate) - SpO2 (Oxygen Saturation) - PVI (Pleth Variability Index) - SpCO (Carboxyhemoglobin) - SpOC (Oxygen Content) - SpHb (Total Hemoglobin) - SpMet (Methemoglobin Saturation) - EtCO2 (End-tidal Carbon Dioxide) Exclusion Criteria: - None defined |
Country | Name | City | State |
---|---|---|---|
United States | Philips | Pittsburgh | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
Philips Clinical & Medical Affairs Global | North American Science Associates, LLC |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Adverse Device Effects | Frequency of Adverse Device Effects (ADE) related to device users - collected from Incident Reporting | through study completion, an average of 1 year | |
Other | Device Deficiencies | Frequency of Device Deficiencies (DD) - data collected from the technical data log recorded in the Tempus Pro at each Monitoring Event and from Product Complaint Reports | through study completion, an average of 1 year | |
Primary | Clinician assessment of 12-lead ECG reports | The proportion of 12-lead ECG pairs that are identical, after a cardiologist's review of printouts from Corsium IntelliSpace (transmitted) ECG and the original ECG from the Tempus Pro device. | through study completion, an average of 1 year | |
Primary | Diagnostic quality of 12-lead | The printed patient record ECG will be independently reviewed for abnormalities and distortion by a clinician. The clinician will note any abnormalities altering diagnostic quality. | through study completion, an average of 1 year | |
Primary | Consistency of transmitted vital signs by Tempus Pro via IntelliSpace Corsium | The number and proportion of patient vital sign data points, comparing direct data with identical units of measure from printouts from IntelliSpace Corsium (transmitted) vital signs and the original vital signs from the Tempus Pro device. | through study completion, an average of 1 year | |
Secondary | Number of all activated alarms | The 'Summary Record of Care' indicates all alarms - for all alarm-settable parameters - were activated at the thresholds set by the user, as indicated in the 'Technical Log' | through study completion, an average of 1 year | |
Secondary | IntelliSpace Corsium transmission | The Summary Record of Care (SRoC) data transmission from Tempus Pro to IntelliSpace Corsium will be independently reviewed for abnormalities and distortion by a clinician. The clinician will note any abnormalities altering diagnostic quality of the transmission. | through study completion, an average of 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00226681 -
Nurses Helping Sudden Cardiac Arrest Survivors Recover After Getting An Implantable Cardioverter Defibrillator (ICD)
|
Phase 1 | |
Recruiting |
NCT05799833 -
Low QRS Voltages in Young Healthy Individuals and Athletes
|
||
Completed |
NCT05636332 -
The Intrepid Clinical Engineering Study
|
N/A | |
Recruiting |
NCT04250857 -
HeartStart FRx Defibrillator Event Registry
|
||
Recruiting |
NCT02816047 -
Austrian Wearable Cardioverter Defibrillator Registry
|
||
Completed |
NCT00918125 -
Educational Videos to Improve Patient Decision Making and Race Disparities in Implantable Cardioverter Defibrillator Use
|
N/A | |
Recruiting |
NCT05135403 -
ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)
|
||
Completed |
NCT03715790 -
Improve SCA Bridge Study
|
||
Recruiting |
NCT03826524 -
Epinephrine Dose: Optimal Versus Standard Evaluation Trial
|
Phase 4 | |
Recruiting |
NCT05855135 -
Assessment of Combined CCM and ICD Device in HFrEF
|
N/A | |
Completed |
NCT03065647 -
ECPR for Refractory Out-Of-Hospital Cardiac Arrest
|
N/A | |
Completed |
NCT02099721 -
Improve Sudden Cardiac Arrest Study
|
N/A | |
Recruiting |
NCT01822145 -
A Feasibility Study on Prediction of an ICD Shock by ICD-derived Data
|
N/A | |
Completed |
NCT01326624 -
Study of the Wearable Defibrillator in Heart-Failure Patients
|
N/A | |
Completed |
NCT03016754 -
Heart Failure Optimization Study
|
||
Terminated |
NCT02481206 -
Wearable Cardioverter Defibrillator in Hemodialysis Patients (WED-HED) Study
|
N/A | |
Not yet recruiting |
NCT06447805 -
Early Double Sequential Defibrillation in Out-of-hospital Cardiac Arrest
|
N/A | |
Enrolling by invitation |
NCT04548804 -
Better Mechanistic Understanding of and Risk Stratification for Ventricular Tachyarrhythmias Through ECGI
|
N/A | |
Completed |
NCT05490459 -
Jewel Electrophysiology (EP) Lab Study
|
N/A | |
Recruiting |
NCT01521208 -
LUCAS Chest Compressor Versus Manual Chest Compression in Out-of-hospital Sudden Cardiac Arrest. LUCAT Trial
|
Phase 3 |